Newsletters
Technology, Discovery & Innovation NewsFactor Sites:       NewsFactor.com     Enterprise Security Today     CRM Daily     Business Report     Sci-Tech Today  
   
This ad will display for the next 20 seconds. Please click for more information, or scroll down to pass the ad, or Close Ad.
Home Computing Digital Life Discovery Space More Topics...
Vblock™ Systems:
Advanced converged infrastructure
increases productivity & lowers costs.

www.vce.com
Business Briefing
Average Rating:
Rate this article:  
Merck Joins Companies Ending Chimpanzee Research
Merck Joins Companies Ending Chimpanzee Research

By The Associated Press
January 31, 2014 9:59AM

Bookmark and Share
Top pharmaceutical companies, including Merck, are phasing out chimpanzee research, amid improved technology, animal alternatives and pressure from animal rights groups, the NIH and Congress. Technology now allows researchers to do initial testing via computer simulations, in bacteria or cells, and in animals as small as fish.
 


Drugmaker Merck & Co. is joining two dozen other pharmaceutical companies and contract laboratories in committing to not use chimpanzees for research.

The growing trend could mean roughly 1,000 chimps in the U.S. used for research or warehoused for many years in laboratory cages could be "retired" to sanctuaries by around 2020.

That's according to Kathleen Conlee of the Humane Society of the United States, which seven years ago began urging companies to phase out all chimp research.

The trend is driven by improved technology, animal alternatives and pressure from animal rights groups, the National Institutes of Health and Congress.

Last June, reacting to an Institute of Medicine study Congress had requested that concluded nearly all chimp research is unnecessary, the NIH announced it would retire and send about 90 percent of government-owned research chimps to the Chimp Haven sanctuary in Keithville, La. It's now home to about 160 chimps, with nearly 60 more to arrive soon.

After several years, the NIH plans to decide whether the remaining chimps in government labs can also be moved to sanctuaries. Roughly 450 other chimps are owned by private labs that do research under contract for drugmakers and other companies.

"It's been a long road in trying to end the use of chimpanzees in research, and we're now at a turning point," Conlee told The Associated Press Thursday. "We're going to keep on (advocating) until the chimpanzees in laboratories are all in sanctuaries."

Merck spokeswoman Caroline Lappetito said the company, based in Whitehouse Station, N.J., decided late last year to stop research on chimpanzees and switch to alternative types of testing.

"The science has advanced, and we don't really need it," Lappetito said.

Merck, the world's third-biggest drugmaker, is the largest to make the switch.

Companies that develop medicines and consumer products such as cosmetics have long used animals to test safety and effectiveness. In the case of experimental medicines, drugmakers must test on animals before the Food and Drug Administration will let them do the human testing needed for approval of a new therapy.

Nearly all animal experiments in the U.S. involve mice, rats and guinea pigs, although some are done on dogs and great apes, almost always chimpanzees.

But animal research, particularly on primates and pet species such as dogs and rabbits, has long drawn criticism from animal rights groups, including protests outside laboratories and at annual shareholder meetings. Besides calling the practice inhumane, activists often have alleged -- and sometimes proven -- that animals were being abused.

Many companies previously said it was necessary to test potential medicines and vaccines on nonhuman primates because they needed an animal in which the anatomy and disease course were very similar to that in humans.

That thinking changed as technology allowed researchers to do initial testing via computer simulations, in bacteria or cells, and in animals as small as fish. Many drugmakers also found ways to do testing on far fewer animals and to limit the discomfort of experiments by using painkillers and tranquilizers. And many of the companies pledging not to use chimps in the future never did so.

British drugmaker GlaxoSmithKline PLC was one of the first to stop research in chimps, back in 2008.

"Research we did on nonhuman primates was kept to a minimum" even before that, said spokeswoman Melinda Stubee.

Because chimpanzees used for commercial medical research generally are confined in the labs of contract testing companies, Conlee said the Humane Society is trying to convince them that there's no longer enough demand to continue warehousing chimpanzees for potential future work. She hopes they'll pay to support those chimpanzees in one of five U.S. accredited sanctuaries for former research chimps.
 


© 2014 Associated Press/AP Online under contract with NewsEdge. All rights reserved.
 

Tell Us What You Think
Comment:

Name:

Just ONE voice:

Posted: 2014-02-19 @ 4:06am PT
Just ONE voice for the voiceless .... joining thousands and thousands of others:

I can't tell you what I think because I'm crying with joy! I'm one of those dedicated activists who demonstrated and marched and begged ALL of the companies to stop research on ALL primates .... and, ALL ANIMALS! This is just the first step, until they also cease and find alternatives for other animals used in experimentation. We finally got through to them, and they lied for years and years and said they needed them. The proof is in this development! But,if they think activists will go away now, they have another thing coming. There are many more species for which experiments must end. Our job is no where near finished yet ..... there's much more to come. Get ready for larger and larger demonstrations and more and more demands made on the experimenters. Many are becoming too ashamed to even admit they do vivisection on animals, and they're becoming more hated every day. Why? Because there's nothing they can do for humans by studying animals! This is a giant first step. Keep informed on the subject and you'll come to see.



APC has an established a reputation for solid products that virtually pay for themselves upon installation. Who has time to spend worrying about system downtime? APC makes it easy for you to focus on business growth instead of business downtime with reliable data center systems and IT solutions. Learn more here.


 Business Briefing
1.   AT&T in $500M Net Video Partnership
2.   High Court To Hear Aereo Dispute
3.   Aereo CEO Speaks Out on Future
4.   Uber Meets Local Lookalikes in Asia
5.   Otherworldly Ambitions of Elon Musk


advertisement
Is Zuckerberg Nuts To Buy Oculus VR?
$2 billion deal for unproven company.
Average Rating:
High Court To Hear Aereo Dispute
Future of television debated in court.
Average Rating:
Aereo CEO Speaks Out on Future
Success hinges on looming court battle.
Average Rating:


advertisement


 Random Bytes
Zynga Launches Mobile FarmVille Tech Stocks: From Giddy to Glum
Google, Rockstar Suit Stays in Calif. Otherworldly Ambitions of Elon Musk
Product Information and Resources for Technology You Can Use To Boost Your Business

Network Security Spotlight
What Verizon's Data Breach Report Can Teach Enterprises
It’s probably not a jaw-dropper, but cyberespionage is officially on the rise. And the use of stolen or misused credentials is still the leading way the bad guys gain access to corporate information.
 
Top Cyberthreats Exposed by Verizon Report
Beyond Heartbleed, there are cyberthreats vying to take down enterprise networks, corrupt smartphones, and wreak havoc on businesses. Verizon is exposing these threats in a new report.
 
Where Do Web Sites Stand, Post-Heartbleed?
A security firm says the vast majority of Web sites have patched themselves to protect against the Heartbleed bug, but now there are questions raised on the reliability of open-source programs.
 

Navigation
Sci-Tech Today
Home/Top News | Computing | Digital Life | Discovery | Space | Innovation | Health | Science News
Environment
NewsFactor Network Enterprise I.T. Sites
NewsFactor Technology News | Enterprise Security Today | CRM Daily

NewsFactor Business and Innovation Sites
Sci-Tech Today | NewsFactor Business Report

NewsFactor Services
FreeNewsFeed | Free Newsletters | XML/RSS Feed

About NewsFactor Network | How To Contact Us | Article Reprints | Careers @ NewsFactor | Services for PR Pros | Top Tech Wire | How To Advertise

Privacy Policy | Terms of Service
© Copyright 2000-2014 NewsFactor Network. All rights reserved. Article rating technology by Blogowogo. Member of Accuserve Ad Network.